Richard P. Bryce - Nov 30, 2023 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Medical Officer
Signature
/s/ Richard P. Bryce
Stock symbol
ENGN
Transactions as of
Nov 30, 2023
Transactions value $
$0
Form type
4
Date filed
12/4/2023, 05:55 PM
Previous filing
Oct 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENGN Stock Option (Right to Buy) Award $0 +153K $0.00 153K Nov 30, 2023 Common Shares 153K $7.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.